The U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) said last week that they are investigating a possible link between Pfizer/BioNTech’s bivalent messenger RNA (mRNA) Comirnaty COVID biologic and an increased risk of a type of ischemic stroke among people 65 years of age and older. Data from the […]
In an interim report published on Mar. 11, 2022, the U.S. Centers for Disease Control and Prevention (CDC) estimates the effectiveness rate of the influenza vaccine at 16 percent during 2021-2022. The rate, which the CDC termed as “not statistically significant,” is based on a study involving 3,636 children, adolescents and adults in the United […]
On Feb. 5, 2021, four days after being given a second dose of the experimental Moderna mRNA COVID-19 vaccine, Kassidi Kurill died reportedly of ‘multiple organ failure.’1 2 She was a healthy 39-year old single Mom with no known health problems, who worked as a surgical tech for several plastic surgeons in Ogden, Utah. An […]
Story Highlights Many health care workers are hesitant to get the experimental COVID-19 vaccines. One of the most common reasons given by health care workers for not getting the vaccine is a lack of data on the long-term effects of the vaccine. The CDC reported that addressing vaccine hesitancy among health care workers is their […]
Story Highlights Weeks after Johnson & Johnson announced that their experimental COVID-19 vaccine was in final, Phase 3 testing, the company has paused the study to evaluate an unexplained illness in a study participant. AstraZeneca’s late-stage vaccine trial is also still on pause in the U.S. after two cases of a neurological illness arose in […]
Of the 45 volunteers in biotechnology company Moderna, Inc.’s Phase 1 human clinical trial on its experimental mRNA-1273 vaccine for COVID-19, only the names of the first two participants have been widely publicized—Jennifer Haller of Seattle, Washington and Neal Browning of Bothell, Washington. The clinical trial began on Mar. 16, 2020 at Kaiser Permanente Washington […]
On Sept. 19, 2019, President Donald Trump signed an Executive Order, “Modernizing Influenza Vaccines in the United State to Promote National Security and Public Health.” Describing mass use of influenza vaccines “to combat seasonal flu” and influenza pandemics as “strengthening our Nation’s public health and security,” he announced the establishment of a National Influenza Vaccine […]